Literature DB >> 2172332

Giant eccrine acrospiroma.

S J Hunt1, D J Santa Cruz, H Kerl.   

Abstract

Four cases of large eccrine acrospiroma (three benign, one malignant) are reported. The benign tumors involved the lower extremities of two women and one man (73 to 89 years of age). The duration of the lesions ranged from 10 to 20 years. The malignant tumor involved the left side of the chest of a 60-year-old man. Its occurrence in a lesion that had been present for 40 years suggested malignant transformation of a pre-existing benign eccrine acrospiroma. Each tumor showed little to no cellular atypia. Mitotic rates (mitotic figures per 10 high-power fields) varied both between and within lesions. Average mitotic rates did not differentiate the benign from the malignant tumors. The most important distinguishing features of large benign eccrine acrospiromas are the relative circumscription, the lack of cellular atypia, and the absence of stromal, perineurial, and angiolymphatic invasion.

Entities:  

Mesh:

Year:  1990        PMID: 2172332     DOI: 10.1016/0190-9622(90)70270-r

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Giant eccrine acrospiroma: A case report and review of the literature.

Authors:  Uður Koçer; Hasan Mete Aksoy; Yiðit Özer Tiftikcioðlu; Dilek Ertoy; Onder Karaaslan
Journal:  Can J Plast Surg       Date:  2003

2.  Large Eccrine Acrospiroma of the Hand.

Authors:  Surya Rao Rao Venkata Mahipathy; Alagar Raja Durairaj; Narayanamurthy Sundaramurthy; Vimal Chander Rajamanohar; Prabu Shankar Sivagnanam
Journal:  J Clin Diagn Res       Date:  2017-07-01

3.  Giant eccrine hidradenoma mimicking a malignant tumor of the salivary gland.

Authors:  Seung Hyun Oh; Chung Hun Kim; Euna Hwang
Journal:  Arch Plast Surg       Date:  2014-07-15

4.  Malignant acrospiroma of chest and abdominal wall treated with chemotherapy.

Authors:  Anis Bandyopadhyay; Mou Das; Sukumar Jana; Anuradha Das
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.